Raepsaet C, Fourie A, Van Hecke A, Verhaeghe S, Beeckman D, et al.
International wound journal. Date of publication 2021 Feb 1;volume 18(1):79-94.
1. Int Wound J. 2021 Feb;18(1):79-94. doi: 10.1111/iwj.13496. Epub 2020 Nov 25.
Management of incontinence-associated dermatitis: A systematic review of
monetary data.
Raepsaet C(1), Fourie A(1), Van Hecke A(1), Verhaeghe S(1), Beeckman
D(1)(2)(3)(4)(5).
Author information:
(1)Skin Integrity Research Group (SKINT), University Centre for Nursing and
Midwifery, Department of Public Health and Primary Care, Ghent University,
Ghent, Belgium.
(2)School of Health Sciences, Örebro University, Örebro, Sweden.
(3)School of Nursing & Midwifery, Royal College of Surgeons in Ireland (RCSI),
Dublin, Ireland.
(4)Research Unit of Plastic Surgery, Department of Clinical Research, Faculty of
Health Sciences, Vejle, Denmark.
(5)School of Nursing and Midwifery, Monash University, Melbourne, Australia.
The objective was to systematically review monetary data related to management
of incontinence-associated dermatitis (IAD) in an adult population. Six
electronic databases were searched: MEDLINE, CINAHL, Web of Science, EMBASE, The
Cochrane Library and EconLit. The search string combined index terms and text
words related to IAD and monetary data. The quality of the articles was assessed
using the consensus on Health Economic Criteria. Results were synthesised
narratively because of methodological heterogeneity. Nine studies were included.
Only direct medical costs were reported. The product cost per application for
prevention ranged between $0.05 and $0.52, and for treatment between $0.20 and
$0.35. The product cost per patient/day for prevention ranged between $0.23 and
$20.17. The product cost of IAD prevention and treatment per patient/day ranged
between $0.57 and $1.08. The cost to treat IAD did not consider the treatment of
secondary infection. The calculation of labour cost and total cost differed
considerably between studies. Summarising monetary data is a challenge because
of heterogeneity in currencies, settings, samples, time horizons, health- and
cost outcome valuation, IAD definition and measurements, and included costs.
Procedures for health economic evaluations are to be clarified to guarantee
valid interpretation and comparison with other studies.
© 2020 The Authors. International Wound Journal published by
Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.
DOI: 10.1111/iwj.13496
PMCID: PMC7948709
PMID: 33236846 [Indexed for MEDLINE]
Conflict of interest statement: All authors declare: all authors had financial
support from Essity Hygiene and Health AB, Gothenburg for the submitted work; no
financial relationships with any organisations that might have an interest in
the submitted work in the previous 3 years; no other relationships or activities
that could appear to have influenced the submitted work. The funder had no role
in the design of the review, data collection, analyses, interpretation of the
results, or the development and submission of the manuscript.
